Sanofi Successfully Hosts the 3rd DREAM AND GO Digital Health Innovation Summit in Shanghai

SHANGHAI, Nov. 19 (Reporter Jiang Ye) -- On the 18th, Sanofi, a globally renowned pharmaceutical and healthcare company, successfully held its third "DREAM AND GO Digital Healthcare Innovation Summit" in Shanghai. Dr. Pius S. Hornstein, President of Sanofi Greater China, and Ted Lai, Chief Digital Officer of Sanofi Greater China, attended the summit. Together with heavyweight industry experts and digital pioneers, they presented a feast of intellectual exchange in the field of medical technology. By openly showcasing the latest achievements and developments in the frontier areas of digital healthcare, Sanofi engaged with industry ecosystem partners through innovation, aiming for cross-industry collaboration, encountering new knowledge, and sparking the innovative power of digital healthcare to change the world.

"The rapid development of China's information technology is reshaping the landscape of the healthcare industry at an unprecedented pace. We clearly perceive the immense potential for digital healthcare to achieve leapfrog development in the future," said Dr. Hoenig, President of Sanofi Greater China. "As a pioneer and leader in the field of digital healthcare, Sanofi will continue to strengthen its strategic layout in China, collaborate with all partners, pool advantageous resources, accelerate the construction of a digital innovation ecosystem, empower profound transformation within China’s healthcare system, and support the digital transition towards Healthy China."

Frontier Topics Summit: Sparking Ideas to Lead the Future

On the same day, Sanofi’s business leaders, R&D pioneers, and medical experts gathered at the summit, joined by 100+ startups, 100+ investors, and 30+ innovation leaders participating both online and offline. The event featured keynote speeches, panel discussions, innovative company roadshows, and fireside chats, offering an immersive experience with disruptive thinking around three major themes in the frontier fields of digital healthcare in the post-pandemic era.

· Digital Therapeutics: Latest policy interpretation and industry analysis on highly innovative digital treatment methods such as cognitive behavioral therapy and software-enabled approaches;

· Early Disease Screening and Prevention: Explored how to effectively conduct early screening and prevention before the clinical symptoms of a disease appear, and improve patient cure rates and health levels through big data technology and online patient education;

· User Experience in the Connected Ecosystem: On-site Dialogue with Industry Giants Unilever and IKEA, Discussing How Enterprises Integrate User Experience into Their Digital Ecosystems to Achieve Service Upgrades in the Internet Era.

High-Energy Gathering of Initial Achievements, Digital Innovation Expanding the Ecosystem

Sanofi was the first to recognize the pioneering value of Chinese startups. At this conference, representatives of the star co-creation project were present at the startup booths, sharing their collaboration stories and achievements with Sanofi. They also invited the audience to explore the industry's cutting-edge developments and gain insights into the vast opportunities within the healthcare and wellness sector, thereby expanding stakeholders' vision of the digital innovation ecosystem's growth.

"The 'Extreme Creation Alliance' has undoubtedly become an incubator that helps accelerate the implementation of our innovative technology concepts. Sanofi has a broad vision, abundant resources, and a deep understanding of China," said Zhang Jie, Director of AI Drug Research at SenseTime. "The Chinese digital healthcare market has vast potential and offers great opportunities. SenseTime Smart Healthcare firmly believes that with the help of cutting-edge technologies such as artificial intelligence, digital innovation will profoundly impact various aspects of drug research and the comprehensive health decision-making processes of doctors and patients."

Alongside SenseTime, prominent participants included Shangyi Information (developer of the SurgiCare App), a leading innovator in China’s digital therapeutics sector; HaoSleep365, the largest online sleep therapy platform in China; and startups such as Weimai, Keji, and Firefly. These entities collectively bridge the present and future of medical scenarios, shining like a constellation of stars. An ecosystem is taking shape, characterized by complementary efforts across the value chain of healthcare innovation. The rapid incubation of these projects, akin to bamboo shoots sprouting after rain, owes much to the determination and driving force at the national level.

Digital Transformation in Healthy China, "Sanofi" Boosts Layout with Strong Support

The successive releases of the "Healthy China 2030 Plan Outline" and the "14th Five-Year Plan" have established the importance of information system construction and smart healthcare in achieving the "Healthy China" strategy. A report by Frost & Sullivan shows that last year, the total market size of China's medical e-commerce was 187 billion yuan, and it is expected to exceed 558 billion yuan by 2025. In the foreseeable future, both healthcare and business models will face a new leap forward, as China’s market stands on the eve of a new era of digital healthcare.

"Since the establishment of the 'Polaris Innovation Alliance' in 2018, Sanofi was the first to enter and gradually built a highly efficient digital innovation team 'in China, for China.' By leveraging digitalization, cutting-edge technology, and big data, along with an agile team working model, Sanofi China is committed to becoming a 'localized multinational company,' further connecting multiple resources and ecosystem partners to integrate into the future healthcare innovation ecosystem." said Ted Lai, Chief Digital Officer of Sanofi Greater China, "The vibrant local startups are the 'organic factors' in this ecosystem. By empowering their most promising projects, we address various pain points in the advancement of digital healthcare, driving the incubation of local innovative potential into highly efficient digital healthcare solutions. In the future, we will even help mature Chinese practices break through boundaries and expand overseas, benefiting patients worldwide."

Next year marks the 40th anniversary of Sanofi's entry into the Chinese market. As a "localized multinational company," Sanofi will aspire to innovation and seize the historical opportunity presented by the digital transformation of "Healthy China." By leveraging the insights of local startups and harnessing the advantages of the "Internet + Healthcare" era, Sanofi aims to explore and meet the healthcare needs of the future. Sanofi will continue to collaborate with the government, experts, industry partners, and stakeholders to jointly establish a brand-new digital healthcare ecosystem in China, striving tirelessly for the health and well-being of the Chinese people. (End)

Note: Please be sure to indicate the source when reprinting the content of the article!

Editor: Jiang Yu